making the transition

GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% is the latest step in Baxter's ongoing efforts toward advancing the science of IVIG.

As distribution of the GAMMAGARD LIQUID continues, you may be transitioned from GAMMAGARD S/D to GAMMAGARD LIQUID. Consult your doctor about the best therapy available.

Baxter will continue to provide GAMMAGARD S/D for IgA-sensitive patients who require a low IgA content in their IVIG therapy.

Please see Important Safety Information and Full Prescribing Information for GAMMAGARD LIQUID.